Additionally, EZH2 inhibition can affect hematopoietic and muscle stem cells, causing issues like blood disorder and impaired muscle repair (Juan et al., 2011; Mochizuki-Kashio et al., 2015). The gene discussed is EZH2; the disease is hematologic disorder.